Katarina Dathe

2.0k total citations
44 papers, 861 citations indexed

About

Katarina Dathe is a scholar working on Public Health, Environmental and Occupational Health, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, Katarina Dathe has authored 44 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Public Health, Environmental and Occupational Health, 13 papers in Obstetrics and Gynecology and 12 papers in Molecular Biology. Recurrent topics in Katarina Dathe's work include Pregnancy and Medication Impact (20 papers), Pregnancy and preeclampsia studies (11 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Katarina Dathe is often cited by papers focused on Pregnancy and Medication Impact (20 papers), Pregnancy and preeclampsia studies (11 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Katarina Dathe collaborates with scholars based in Germany, United States and Hong Kong. Katarina Dathe's co-authors include Christof Schaefer, Stefan Mundlos, Petra Seemann, Eva Klopocki, Anja Brehm, Stephanie Padberg, Evelin Beck, Randi Koll, Peter Meinecke and Claus‐Eric Ott and has published in prestigious journals such as Journal of Molecular Biology, Scientific Reports and The American Journal of Human Genetics.

In The Last Decade

Katarina Dathe

37 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katarina Dathe Germany 14 402 263 168 116 114 44 861
Junlong Zhang China 16 232 0.6× 50 0.2× 86 0.5× 126 1.1× 165 1.4× 48 754
Atsushi Yoshida Japan 14 171 0.4× 137 0.5× 133 0.8× 40 0.3× 187 1.6× 41 608
Şafak Güçer Türkiye 18 326 0.8× 132 0.5× 54 0.3× 199 1.7× 58 0.5× 62 870
Sara Salehi Hammerstad Norway 13 114 0.3× 240 0.9× 44 0.3× 129 1.1× 20 0.2× 24 740
Toshio Yanagihara Japan 17 351 0.9× 172 0.7× 58 0.3× 42 0.4× 78 0.7× 36 1.1k
Kang Chao China 17 290 0.7× 345 1.3× 138 0.8× 182 1.6× 38 0.3× 65 939
L. Villarreal Mexico 14 159 0.4× 102 0.4× 54 0.3× 46 0.4× 89 0.8× 97 553
Liyi Cai Japan 15 282 0.7× 137 0.5× 199 1.2× 40 0.3× 293 2.6× 31 730
Juan Luís Fernández-Morera Spain 17 216 0.5× 84 0.3× 18 0.1× 79 0.7× 60 0.5× 28 839
Hong Xin China 14 169 0.4× 31 0.1× 42 0.3× 80 0.7× 136 1.2× 32 654

Countries citing papers authored by Katarina Dathe

Since Specialization
Citations

This map shows the geographic impact of Katarina Dathe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarina Dathe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarina Dathe more than expected).

Fields of papers citing papers by Katarina Dathe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarina Dathe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarina Dathe. The network helps show where Katarina Dathe may publish in the future.

Co-authorship network of co-authors of Katarina Dathe

This figure shows the co-authorship network connecting the top 25 collaborators of Katarina Dathe. A scholar is included among the top collaborators of Katarina Dathe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarina Dathe. Katarina Dathe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Padberg, Stephanie, Brigitte Keller‐Stanislawski, Doris Oberle, et al.. (2025). First trimester mRNA COVID-19 vaccination and risk of congenital malformation: a prospective observational Embryotox cohort study. Clinical Microbiology and Infection. 31(9). 1571–1578.
3.
Hoeltzenbein, Maria, et al.. (2024). Trends in use of antiseizure medication and treatment pattern during the first trimester in the German Embryotox cohort. Scientific Reports. 14(1). 30585–30585.
4.
Padberg, Stephanie, et al.. (2024). Impact of maternal first trimester treatment regimen on the outcome of valproate exposed pregnancies: an observational Embryotox cohort study. Scientific Reports. 14(1). 674–674. 3 indexed citations
5.
Padberg, Stephanie, et al.. (2023). An observational study on safety of COVID-19 vaccines in pregnancy – Current status and preliminary data based on the Embryotox cohort. Neurotoxicology and Teratology. 98. 107244–107244. 1 indexed citations
6.
Hoeltzenbein, Maria, et al.. (2023). Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. 107. 107–113. 12 indexed citations
7.
Hoeltzenbein, Maria, et al.. (2023). Antiepileptic treatment with levetiracetam during the first trimester and pregnancy outcome: An observational study. Epilepsia. 65(1). 26–36. 4 indexed citations
8.
Haug, Ulrike, Bianca Kollhorst, Tania Schink, et al.. (2022). Investigating drug safety in pregnancy based on the German Pharmacoepidemiological Research Database (GePaRD): A proof‐of‐concept analysis on the association between valproate and spina bifida. Pharmacoepidemiology and Drug Safety. 32(2). 148–157. 6 indexed citations
9.
Dathe, Katarina, et al.. (2022). Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort. BMC Pregnancy and Childbirth. 22(1). 666–666. 14 indexed citations
10.
Hoeltzenbein, Maria, Marie‐Louise Lehmann, Evelin Beck, Katarina Dathe, & Christof Schaefer. (2021). Ivabradine use in pregnant women—treatment indications and pregnancy outcome: an evaluation of the German Embryotox database. European Journal of Clinical Pharmacology. 77(7). 1029–1037. 5 indexed citations
11.
Dathe, Katarina, et al.. (2019). Risk estimation of fetal adverse effects after short-term second trimester exposure to non-steroidal anti-inflammatory drugs: a literature review. European Journal of Clinical Pharmacology. 75(10). 1347–1353. 25 indexed citations
12.
Dathe, Katarina & Christof Schaefer. (2019). The Use of Medication in Pregnancy. Deutsches Ärzteblatt international. 116(46). 783–790. 38 indexed citations
13.
Dathe, Katarina, et al.. (2018). No evidence of adverse pregnancy outcome after exposure to ibuprofen in the first trimester – Evaluation of the national Embryotox cohort. Reproductive Toxicology. 79. 32–38. 20 indexed citations
14.
Dathe, Katarina, et al.. (2017). Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study. European Journal of Clinical Pharmacology. 74(4). 489–495. 15 indexed citations
15.
Dathe, Katarina, Evelin Beck, & Christof Schaefer. (2016). Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database. Reproductive Toxicology. 65. 39–45. 16 indexed citations
16.
Zimmer, Julia, Maria Walther, Carsten Reißner, et al.. (2013). A GDF5 Point Mutation Strikes Twice - Causing BDA1 and SYNS2. PLoS Genetics. 9(10). e1003846–e1003846. 34 indexed citations
17.
Gerbes, Alexander L., T. Sauerbruch, & Katarina Dathe. (2011). Leitlinienmethodenreport zur S3-Leitlinie „Aszites, spontan bakterielle Peritonitis, hepatorenales Syndrom”. Zeitschrift für Gastroenterologie. 49(6). 780–787. 7 indexed citations
18.
Klopocki, Eva, Bianca P. Hennig, Katarina Dathe, et al.. (2010). Deletion and Point Mutations of PTHLH Cause Brachydactyly Type E. The American Journal of Human Genetics. 86(3). 434–439. 93 indexed citations
19.
Dathe, Katarina, Klaus Kjaer, Anja Brehm, et al.. (2009). Duplications Involving a Conserved Regulatory Element Downstream of BMP2 Are Associated with Brachydactyly Type A2. The American Journal of Human Genetics. 84(4). 483–492. 120 indexed citations
20.
Arnold, R., et al.. (2009). Status quo Gastroenterologie. Zeitschrift für Gastroenterologie. 47(6). 563–574. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junlong Zhang Breakdown of academic impact, for papers by Atsushi Yoshida Breakdown of academic impact, for papers by Şafak Güçer Breakdown of academic impact, for papers by Sara Salehi Hammerstad Breakdown of academic impact, for papers by Toshio Yanagihara Breakdown of academic impact, for papers by Kang Chao Breakdown of academic impact, for papers by L. Villarreal Breakdown of academic impact, for papers by Liyi Cai Breakdown of academic impact, for papers by Juan Luís Fernández-Morera Breakdown of academic impact, for papers by Hong Xin
Rankless by CCL
2026